Article | September 25, 2013, 5.04 PM IST

Embrace Innovations founder on keeping Indian infants warm

Jane Marie Chen
Age: 32
Designation: CEO and co-founder, Embrace Innovations. It sells low-cost infant warmers for low-birth-weight and premature babies in developing nations. It has partnered with multinationals like GE Healthcare to address infant mortality.
Education: Master’s in Public Administration from Harvard University; MBA from Stanford University

I came to India twice before moving here in 2009 to start the India office for Embrace. My first impressions were very chaotic. What struck me most was the disparity. Many of my Stanford classmates in Mumbai and Delhi were from very affluent backgrounds. Visiting them and then going back to the slums right outside the city, where infant mortality was so high, was quite shocking for me. It felt that a lot of people had become numb to the situation and were turning a blind eye. I also saw a lot of hope. I met a number of amazing doctors who were doing incredible work.

I moved to Hong Kong right after college and was working as a management consultant in an American firm. One day I read an article in The New York Times about how millions of poor farmers in China had contracted HIV through selling blood. Under this government-run scheme, hospitals would pool all the blood, separate the plasma, and re-inject the remaining RBCs into each person thinking it would allow them to give blood quickly.

When I read the piece, something happened to me. I quit my job and joined an NGO, which was helping children orphaned due to HIV. It was a remarkable experience. I learnt that a small group of dedicated, passionate people taking small steps could affect social change. I also saw this huge health care disparity. In the US, anyone who needed AIDS drugs could get it. In China and later in Africa, I saw many people dying because they couldn’t access these medications. For me, Embrace is not about a product; it is about building a platform by which we can reduce this disparity.

It’s been very challenging; there is no established infrastructure or distributors or even medical protocols in India for the kind of work we want to do. It forces you to be very entrepreneurial. I really like the term jugaad; it characterises India so well and what you have to do to survive.

When we first landed here, we had no idea about how to get our clinical studies done. We didn’t have any contacts, so we took the yellow pages and went door-to-door, doctor-to-doctor in Mumbai and Delhi. That is how we ended up meeting some really good doctors in Bangalore who are now a part of our advisory panel.
In India, it was so difficult to set up an office or even a bank account; in Hong Kong I could do that in a day. And yet, we have been able to do a lot here. Once we were able to find the believers, they went really far to support us. NRN Murthy [Narayana Murthy of Infosys] is a supporter of our nonprofit. He is one of the most amazing people I have met in my life. He was very busy but was willing to make personal connections for us. He put his name behind Embrace. A lot of India is, unfortunately, who you know.

My big learning last year was, just because there is a need, as demonstrated by the numbers, it doesn’t mean there is a demand for your product. When we started to sink our teeth in the private sector, a lot of people said doctors are only motivated by money. It’s true of any country. But in order to do this kind of work, you have to be very deliberate about the lens through which you see the world.

There will always be doctors who truly want to help their patients. And if you look for them, you will find them. As opposed to if you just come here with the notion that everyone is all about economics. You have to be deliberate about the point of view you want to take.

Know more about GE Healthcare products

Tags : Mumbai, China, HIV, Infosys, Embrace Innovations, AIDS, medical protocols, keeping infants warm, babies

Video of the Week

How Discovery IQ can improve outcomes for cancer patients
Terri Bresenham, President & CEO, GE Healthcare,

Read more »

Trending Now

Frugal innovations: The next big thing in healthcare
Given how crucial cancer screening is, the

Read more »

RElated Stories

How Discovery IQ will impact cancer management in India
Milan Rao, COO, Wipro GE Healthcare, speaks about the excitement surrounding the Discovery IQ PET/CT...

India's cancer report card: 2012 vs 2035
Cancer deaths are projected to rise to 1.2 million in 2035 from 0.7 million in 2012

Making cancer care in India economical
Dr. RV Parameswaran, Head of Nuclear Medicine at Manipal Hospital, speaks about how important it is in...

In the next 10 years, will our import dependence on crude oil come down?

  • Yes
  • No


Follow GE India on
Copyright 2015 Network18. All Rights Reserved. Process Content Powered by

Get access to the FREE Industry Newsletter

Thank you for subscribing

Please whitelist to receive
this email in your inbox.